A Randomized Controlled Trial Comparing Liraglutide vs. Glargine Insulin for the Management of Patients with Type 2 Diabetes after Hospital Discharge

被引：0
|
作者：
Pasquel, Francisco J.
Urrutia, Maria A.
Cardona, Saumeth
Iacobellis, Gianluca
Farias, Javier, Sr.
Chaudhuri, Ajay
Anzola, Isabel
Palacios, Juan D.
Albury, Bonnie S.
Gomez, Patricia C.
Zamudio, Karla W.
Perez-Guzman, Mireya C.
Vellanki, Priyathama
Fayfman, Maya
Haw, Jeehea Sonya
Galindo, Rodolfo J.
Davis, Georgia
Migdal, Alexandra
Peng, Limin
Umpierrez, Guillermo E.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-963-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
963-P
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial
    Dashora, U. K.
    Sibal, L.
    Ashwell, S. G.
    Home, P. D.
    DIABETIC MEDICINE, 2007, 24 (04) : 344 - 349
  • [22] Cardiovascular Events in Type-2-Diabetes: Insulin Degludec vs. Glargine
    Lichert, Frank
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1642 - +
  • [23] Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes The SWITCH 2 Randomized Clinical Trial
    Wysham, Carol
    Bhargava, Anuj
    Chaykin, Louis
    de la Rosa, Raymond
    Handelsman, Yehuda
    Troelsen, Lone N.
    Kvist, Kajsa
    Norwood, Paul
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (01): : 45 - 56
  • [24] Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues
    Alcolado, J.
    Poole, C. D.
    Peters, J. R.
    Currie, C. J.
    DIABETIC MEDICINE, 2008, 25 (01) : 115 - 116
  • [25] Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial
    Nordklint, A. K.
    Almdal, T. P.
    Vestergaard, P.
    Lundby-Christensen, L.
    Boesgaard, T. W.
    Breum, L.
    Gade-Rasmussen, B.
    Sneppen, S. B.
    Gluud, C.
    Hemmingsen, B.
    Perrild, H.
    Madsbad, S.
    Mathiesen, E. R.
    Tarnow, L.
    Thorsteinsson, B.
    Vestergaard, H.
    Lund, S. S.
    Eiken, P.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (09) : 1837 - 1848
  • [26] Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial
    A. K. Nordklint
    T.P. Almdal
    P. Vestergaard
    L. Lundby-Christensen
    T.W. Boesgaard
    L. Breum
    B. Gade-Rasmussen
    S.B. Sneppen
    C. Gluud
    B. Hemmingsen
    H. Perrild
    S. Madsbad
    E.R. Mathiesen
    L. Tarnow
    B. Thorsteinsson
    H. Vestergaard
    S.S. Lund
    P. Eiken
    Osteoporosis International, 2021, 32 : 1837 - 1848
  • [27] Therapy in type 2 diabetes: Insulin glargine vs. 2 NPH insulin both in combination with glimepiride
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (04) : 495 - 501
  • [28] In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin
    Brown, Krysta
    Donato, Anthony A.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : JC9 - JC9
  • [29] Basal Insulin Substitution with Glargine or CSII in Adult Type I Diabetes Patients-A Randomized Controlled Trial
    Bragd, Joakim
    Adamson, Ulf
    Lins, Per-Eric
    Von Dobeln, Anna
    Oskarsson, Per
    DIABETES, 2009, 58 : A60 - A61
  • [30] Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial
    Takase, Takahiro
    Nakamura, Akinobu
    Yamamoto, Chiho
    Nomoto, Hiroshi
    Miya, Aika
    Dannoura, Midori
    Cho, Kyu Yong
    Kurihara, Yoshio
    Manda, Naoki
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 699 - 705
12345